699 related articles for article (PubMed ID: 20545754)
1. Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy.
Canevini MP; De Sarro G; Galimberti CA; Gatti G; Licchetta L; Malerba A; Muscas G; La Neve A; Striano P; Perucca E;
Epilepsia; 2010 May; 51(5):797-804. PubMed ID: 20545754
[TBL] [Abstract][Full Text] [Related]
2. Antiepileptic drug utilization in Taiwan: analysis of prescription using National Health Insurance database.
Hsieh LP; Huang CY
Epilepsy Res; 2009 Mar; 84(1):21-7. PubMed ID: 19135869
[TBL] [Abstract][Full Text] [Related]
3. Sociodemographic differences in antiepileptic drug prescriptions to adult epilepsy patients.
Mattsson P; Tomson T; Eriksson O; Brännström L; Weitoft GR
Neurology; 2010 Jan; 74(4):295-301. PubMed ID: 20101034
[TBL] [Abstract][Full Text] [Related]
4. Adverse effects & drug load of antiepileptic drugs in patients with epilepsy: Monotherapy versus polytherapy.
Joshi R; Tripathi M; Gupta P; Gulati S; Gupta YK
Indian J Med Res; 2017 Mar; 145(3):317-326. PubMed ID: 28749393
[TBL] [Abstract][Full Text] [Related]
5. Non-interventional surveillance study of adverse events in patients with epilepsy.
Cramer JA; Steinborn B; Striano P; Hlinkova L; Bergmann A; Bacos I; Baukens C; Buyle S
Acta Neurol Scand; 2011 Jul; 124(1):13-21. PubMed ID: 21039365
[TBL] [Abstract][Full Text] [Related]
6. Determinants of health-related quality of life in pharmacoresistant epilepsy: results from a large multicenter study of consecutively enrolled patients using validated quantitative assessments.
Luoni C; Bisulli F; Canevini MP; De Sarro G; Fattore C; Galimberti CA; Gatti G; La Neve A; Muscas G; Specchio LM; Striano S; Perucca E;
Epilepsia; 2011 Dec; 52(12):2181-91. PubMed ID: 22136077
[TBL] [Abstract][Full Text] [Related]
7. Focal epilepsies in adult patients attending two epilepsy centers: classification of drug-resistance, assessment of risk factors, and usefulness of "new" antiepileptic drugs.
Gilioli I; Vignoli A; Visani E; Casazza M; Canafoglia L; Chiesa V; Gardella E; La Briola F; Panzica F; Avanzini G; Canevini MP; Franceschetti S; Binelli S
Epilepsia; 2012 Apr; 53(4):733-40. PubMed ID: 22360822
[TBL] [Abstract][Full Text] [Related]
8. Strategies to detect adverse effects of antiepileptic drugs in clinical practice.
Carreño M; Gil-Nagel A; Sánchez JC; Elices E; Serratosa JM; Salas-Puig J; Villanueva V; Porcel J
Epilepsy Behav; 2008 Jul; 13(1):178-83. PubMed ID: 18353732
[TBL] [Abstract][Full Text] [Related]
9. Antiepileptic drugs in Australia: 2002-2007.
Hollingworth SA; Eadie MJ
Pharmacoepidemiol Drug Saf; 2010 Jan; 19(1):82-9. PubMed ID: 19802824
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures: a randomized, double-blind, placebo-controlled, parallel-group phase III study.
Elger C; Halász P; Maia J; Almeida L; Soares-da-Silva P;
Epilepsia; 2009 Mar; 50(3):454-63. PubMed ID: 19243424
[TBL] [Abstract][Full Text] [Related]
11. Challenging epilepsy with antiepileptic pharmacotherapy in a tertiary teaching hospital in Sri Lanka.
Kariyawasam SH; Bandara N; Koralagama A; Senanayake S
Neurol India; 2004 Jun; 52(2):233-7. PubMed ID: 15269479
[TBL] [Abstract][Full Text] [Related]
12. Quantifying the response to antiepileptic drugs: effect of past treatment history.
Schiller Y; Najjar Y
Neurology; 2008 Jan; 70(1):54-65. PubMed ID: 18166707
[TBL] [Abstract][Full Text] [Related]
13. Pharmacoepidemiology in community-dwelling elderly taking antiepileptic drugs.
Berlowitz DR; Pugh MJ
Int Rev Neurobiol; 2007; 81():153-63. PubMed ID: 17433922
[TBL] [Abstract][Full Text] [Related]
14. Prescription patterns of antiepileptic drugs in patients with epilepsy in a nation-wide population.
Landmark CJ; Fossmark H; Larsson PG; Rytter E; Johannessen SI
Epilepsy Res; 2011 Jun; 95(1-2):51-9. PubMed ID: 21435840
[TBL] [Abstract][Full Text] [Related]
15. [Classic antiepileptic and new generation antiepileptic drugs: gender differences in effectiveness and adverse drug reactions].
Falip M; Artazcoz L; de la Peña P; Pérez-Sempere A; Martín-Moro M; Codina M;
Neurologia; 2005 Mar; 20(2):71-6. PubMed ID: 15726473
[TBL] [Abstract][Full Text] [Related]
16. Pattern of adverse drug reactions to anti-epileptic drugs: a cross-sectional one-year survey at a tertiary care hospital.
S RB; Narayan SS; Sharma GR; Rodrigues RJ; Kulkarni C
Pharmacoepidemiol Drug Saf; 2008 Aug; 17(8):807-12. PubMed ID: 18213610
[TBL] [Abstract][Full Text] [Related]
17. Compulsory generic switching of antiepileptic drugs: high switchback rates to branded compounds compared with other drug classes.
Andermann F; Duh MS; Gosselin A; Paradis PE
Epilepsia; 2007 Mar; 48(3):464-9. PubMed ID: 17346246
[TBL] [Abstract][Full Text] [Related]
18. Evolving antiepileptic drug treatment in juvenile myoclonic epilepsy.
Prasad A; Kuzniecky RI; Knowlton RC; Welty TE; Martin RC; Mendez M; Faught RE
Arch Neurol; 2003 Aug; 60(8):1100-5. PubMed ID: 12925366
[TBL] [Abstract][Full Text] [Related]
19. Open-label, long-term safety study of zonisamide administered to children and adolescents with epilepsy.
Shinnar S; Pellock JM; Conry JA
Eur J Paediatr Neurol; 2009 Jan; 13(1):3-9. PubMed ID: 18343174
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the cognitive effects of tiagabine and carbamazepine as monotherapy in newly diagnosed adult patients with partial epilepsy: pooled analysis of two long-term, randomized, follow-up studies.
Aikiä M; Jutila L; Salmenperä T; Mervaala E; Kälviäinen R
Epilepsia; 2006 Jul; 47(7):1121-7. PubMed ID: 16886974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
